We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology

Video   Mar 17, 2015

 


About the Speaker
Andreas Jeromin, PhD, has established research programs in translational neuroscience in both industry and biotech for the last 15 years and co-authored more than 100 publications. He has also been elected a member of the Dana Alliance for Brain Initiatives. Andreas Jeromin has led biomarker qualification programs in diagnostics and therapeutics in acute neurological injury and neurodegeneration in roles with increased responsibilities. This included several drug development program from POC to a NINDS-supported phase III trial (Protect III). He also supports as member of the SABs or steering committee, several biomarker qualification efforts such as ADNI, the Coalition against Major Diseases (CAMD) directed by the Critical Path Institute (C-PATH), the Alzheimer's Association CSF QC and biomarker assay standardization initiatives in other CNS disorders, including MS (Accelerated Cure), ALS and PD. He is the founder and CSO of Atlantic Biomarkers, LLC, and joined Quanterix, Inc. as scientific and medical advisor in 2014.

 
 
 
 

Recommended Videos

MRI-algorithm Can Identify Suicidal Thoughts

Video

An innovative and promising approach has been developed to identify suicidal individuals by analyzing alterations in how their brains represent certain concepts, such as death, cruelty and trouble.

WATCH NOW

What is Sepsis?

Video

Learn about the most preventable cause of death worldwide, in 3 minutes. Save lives and raise awareness by sharing this video with your friends, family and colleagues.

WATCH NOW

Why Are Polygenic Risk Scores Important?

Video

Dr Sekar Kathiresan highlights the importance of polygenic risk scoring, a method which summarizes data into a single variable that measures genetic liability to a disorder or a trait.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE